한글목차

세계 효소 결합 면역 흡착 분석법(ELISA) 검사 시장의 잠재력은 병원 및 진단센터, 제약 및 생명공학 기업, 학술연구센터, 임상 검사 시장 등의 기회로 인해 유망한 시장으로 평가받고 있습니다. 효소 결합 면역 흡착 측정법(ELISA법) 세계 시장은 2025-2031년 연평균 7.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 HIV, 뎅기열, 간염, 말라리아, 독감 등 감염성 질환의 유행이 확대되고 있으며, 여러 감염성 질환에 걸릴 위험이 있는 노년층이 증가하고 있다는 점입니다.

• Lucintel의 예측에 따르면 유형별로는 휴대성과 현재 진행 중인 기술 발전으로 인해 멀티포터블 ELISA가 예측 기간 중 가장 높은 성장세를 보일 것으로 예측됩니다.
• 최종 용도별로는 질병 유병률 증가, 맞춤형 의료에 대한 수요 증가, ELISA 검사에 대한 정부 지원 증가로 인해 병원 및 진단센터가 가장 큰 부문이 될 것으로 예측됩니다.
• 지역별로는 북미가 고령 인구의 급증, 의료기기 보급률 상승, 첨단화된 의료 인프라의 존재로 인해 예측 기간 중 가장 규모가 큰 지역으로 남을 것으로 보입니다.

효소 결합 면역 흡착 분석법(ELISA) 시장의 전략적 성장 기회

ELISA 검사 시장은 다양한 용도에서 몇 가지 전략적 성장 기회를 제공합니다.

• 질병 진단: 질병 진단: 신종 질병 및 감염성 질환의 진단에 ELISA법의 활용이 확대됨에 따라 적시에 특이적인 동정이 가능해져 큰 성장 가능성이 예상됩니다.
• 의약품 개발 연구: 의약품 개발 연구: 의약품 개발, 특히 약동학 모니터링 및 치료 표적 검증에서 ELISA 검사의 활용이 증가하고 있으며, 이는 의약품에 있으며, 귀중한 기회가 되고 있습니다.
• 환경 모니터링: 오염물질 및 독소의 환경 모니터링에 대한 ELISA 적용은 규제 압력과 환경 문제에 대한 우려에 힘입어 증가하고 있습니다.
• 식품 안전: 식품 안전에 대한 규제가 강화되고 소비자의 인식이 높아짐에 따라 오염물질 및 알레르겐 검출을 위한 식품 검사에 ELISA가 필수적인 요소로 자리 잡고 있습니다.
• 임상 연구: ELISA는 바이오마커 발굴 및 검증에 중요한 역할을 하며, 맞춤형 의료 및 표적 치료를 지원함으로써 새로운 시장 기능을 개발하고 있습니다.

이 부문에서의 ELISA 적용 확대가 시장 성장을 촉진하고 있습니다.

효소 결합 면역 흡착 분석법(ELISA) 검사 시장 성장 촉진요인 및 과제

ELISA 검사 시장에 영향을 미치는 요인은 기술, 경제, 규제 등 다양합니다. 여기서는 주요 촉진요인과 과제를 분석합니다.

효소 결합 면역 흡착 측정법(ELISA법) 시장을 촉진하는 요인은 다음과 같습니다.

• 기술 진보: 기술 진보: 새로운 ELISA 기술의 발명 및 개발, 자동화, 민감도 향상 등으로 검사 출력과 정확도가 향상되어 시장 개발의 원동력이 되고 있습니다.
• 질병 유병률 증가: 만성질환 및 감염성 질환의 유병률이 증가하고 있습니다. 이에 따라 ELISA 검사를 포함한 효과적이고 신뢰할 수 있는 진단 툴에 대한 수요가 증가하고 있습니다.
• 정부의 구상: 정부의 우호적인 정책과 연구 및 의료 인프라에 대한 투자가 ELISA 시장을 강화하고 있습니다.
• 인식 증가: 질병의 조기 진단과 맞춤형 의료에 대한 인식이 높아짐에 따라 ELISA 검사의 채택이 증가하고 있습니다.
• 용도 증가: 임상 진단 및 모니터링 등 응용 범위의 확대가 새로운 시장 기회를 창출하고 있습니다.

효소 결합 면역 흡착 분석법(ELISA) 검사 시장 과제는 다음과 같습니다.

• 높은 비용: 고급 ELISA 시스템 및 시약 비용은 자원이 부족한 환경에서 사용을 제한할 수 있습니다.
• 규제 장애물: ELISA 검사의 승인 및 검증에 대한 엄격한 규제 요건은 시장 진입을 지연시키고 개발 비용을 증가시킬 수 있습니다.

이러한 시장 성장 촉진요인과 과제가 ELISA 시장을 형성하고 이해관계자들의 전략적 의사결정에 영향을 미치고 있습니다.

목차

제1장 개요

제2장 세계의 효소 면역측정법(ELISA) 검사 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 산업 촉진요인과 과제

제3장 2019-2031년 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 효소 면역측정법(ELISA) 검사 시장 동향(2019-2024년)과 예측(2025-2031년)
• 유형별 세계의 효소 면역측정법(ELISA) 검사 시장
  • 샌드위치 ELISA
  • 간접 ELISA
  • 멀티와 휴대용 ELISA
  • 경쟁 ELISA
• 용도별 세계의 효소 면역측정법(ELISA) 검사 시장
  • 면역학
  • 백신 개발
  • 감염증
  • 암
  • 단백질 정량
  • 기타
• 최종 용도별 세계의 효소 면역측정법(ELISA) 검사 시장
  • 병원으로 진단 센터
  • 제약·바이오테크놀러지 기업
  • 학술연구 센터
  • 임상 검사실
  • 기타

제4장 2019-2031년 지역별 시장 동향과 예측 분석

• 지역의 효소 면역측정법(ELISA) 검사 시장
• 북미의 효소 면역측정법(ELISA) 검사 시장
• 유럽의 효소 면역측정법(ELISA) 검사 시장
• 아시아태평양의 효소 면역측정법(ELISA) 검사 시장
• 기타 지역의 효소 면역측정법(ELISA) 검사 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 세계의 효소 면역측정법(ELISA) 검사 시장의 성장 기회
  • 용도별 세계의 효소 면역측정법(ELISA) 검사 시장의 성장 기회
  • 최종 용도별 세계의 효소 면역측정법(ELISA) 검사 시장의 성장 기회
  • 지역별 효소 면역측정법(ELISA) 검사 시장의 성장 기회
• 세계의 효소 면역측정법(ELISA) 검사 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 효소 면역측정법(ELISA) 검사 시장의 능력 확대
  • 세계의 효소 면역측정법(ELISA) 검사 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 개요

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

영문목차

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others, and the growing geriatric population who are at risk of developing several infections.

• Lucintel forecasts that, within the type category, multiple and portable ELISA is expected to witness the highest growth over the forecast period due to portability and on-going technological advancements.
• Within the end use category, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market is shaped by several key trends:

• High-Throughput Screening: Automation enables laboratories to adopt high-throughput screening, significantly speeding up sample processing and reducing turnaround times, thus enhancing productivity.
• Multiplex ELISA: The development of multiplex ELISA tests allows for the simultaneous detection of multiple targets, improving diagnostic accuracy and streamlining workflows by reducing the need for multiple tests.
• Integration with Digital Platforms: Increasing integration of ELISA systems with digital platforms for data management and analysis enhances result precision and reproducibility through advanced software solutions.
• Point-of-Care Testing (POCT): There is growing interest in portable and user-friendly ELISA devices for POCT, providing timely diagnostics, especially in remote or underserved areas.
• Personalized Medicine: ELISA technologies are being adapted for personalized medicine, enabling tailored diagnostic and therapeutic strategies based on individual patient profiles and genetic information.

These trends contribute to the efficiency, accuracy, and accessibility of ELISA tests, driving innovation across various healthcare and research applications.

Recent Developments in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Technological innovations and the rising demand for accurate diagnoses are propelling growth in the ELISA test market. Key developments include:

• Automation Integration: Automated ELISA systems are transforming laboratory operations by increasing sample throughput and reducing human error, resulting in more consistent and reliable performance.
• Improved Sensitivity: Advancements in ELISA technology have significantly enhanced assay sensitivity, enabling the detection of low analyte levels and facilitating early disease diagnosis.
• Portable ELISA Devices: The emergence of portable ELISA devices expands testing capabilities beyond laboratories, allowing for seamless testing in remote or resource-limited settings.
• Customizable ELISA Kits: The market is seeing more customizable ELISA kits designed for specific research or disease targets, providing greater flexibility and precision in diagnostics.
• Sustainable Practices: Manufacturers are increasingly focusing on sustainable practices, aiming to reduce waste and use eco-friendly materials in the production of ELISA kits and reagents.

These advancements are enhancing diagnostic capabilities and expanding the scope of ELISA tests.

Strategic Growth Opportunities for Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market offers several strategic growth opportunities across various applications:

• Disease Diagnostics: Expanding the use of ELISA for diagnosing emerging and infectious diseases presents significant growth potential for timely and specific identification.
• Drug Development Studies: ELISA tests are increasingly utilized in drug development, particularly for monitoring pharmacokinetics and validating therapeutic targets, presenting a valuable opportunity in pharmaceuticals.
• Environmental Monitoring: ELISA applications in environmental monitoring for pollutants and toxins are growing, driven by regulatory pressures and environmental concerns.
• Food Safety: ELISA is becoming essential in food testing to detect contaminants and allergens, spurred by increasing food safety regulations and consumer awareness.
• Clinical Research: ELISA plays a critical role in biomarker discovery and validation, supporting personalized medicine and targeted therapies, thus opening new market capabilities.

The expansion of ELISA applications across these sectors is fueling market growth.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Driver and Challenges

Factors influencing the ELISA tests market range from technological, and economic, to regulatory. Here is an analysis of some of the important drivers and challenges:

The factors responsible for driving the enzyme-linked immunosorbent assay (ELISA) tests market include:

• Technological Advancements: Invention and development of new ELISA technologies instance, automation and improved sensitivity-have raised the output and precision of the tests, hence driving market growth.
• Increased Disease Prevalence: There is now a greater incidence of chronic and infectious diseases. This, in turn, is driving demand for effective and reliable diagnostic tools, which include ELISA tests.
• Government Initiatives: Favorable government policies and investments in research and health infrastructure enhance the ELISA market.
• Rising Awareness: Growing awareness of early disease diagnosis and personalized medicine promotes increased adoption of ELISA tests.
• Increasing Applications: The broadening range of applications, including clinical diagnostics and monitoring, creates new market opportunities.

Challenges in the enzyme-linked immunosorbent assay (ELISA) tests market are:

• High Costs: The cost of advanced ELISA systems and reagents may limit their accessibility in resource-poor settings.
• Regulatory Hurdles: Stringent regulatory requirements for the approval and validation of ELISA tests can delay market entry and increase development costs.

These drivers and challenges are shaping the ELISA market and influencing strategic decisions among stakeholders.

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests market by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Analysis by Value from 2019 to 2031]:

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA
• Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Analysis by Value from 2019 to 2031]:

• Immunology
• Vaccine Development
• Infectious diseases
• Cancer
• Protein quantitation
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Clinical Laboratories
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA test market is rapidly evolving with technological advancements and growing diagnostic demands. Recent developments in key markets include:

• United States: Innovation is thriving, with various high-throughput ELISA systems enhancing efficiency and accuracy to meet diagnostic and research demands.
• China: There is a focus on developing low-cost ELISA tests to improve accessibility in both urban and rural areas, supported by government initiatives to strengthen public health infrastructure.
• Germany: Companies are incorporating automation and digitalization into ELISA technology, maximizing laboratory workflow benefits for diagnostics and research.
• India: The increasing manufacturing of ELISA kits in India is reducing reliance on imports, enhancing the cost-effectiveness and accessibility of diagnostic tools.
• Japan: Japan is leading in developing multiplex ELISA tests, capable of detecting multiple analytes simultaneously, thus improving disease detection and monitoring efficiency.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by various segments, such as by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 3.3.1: Sandwich ELISA
  • 3.3.2: Indirect ELISA
  • 3.3.3: Multiple and portable ELISA
  • 3.3.4: Competitive ELISA
• 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 3.4.1: Immunology
  • 3.4.2: Vaccine Development
  • 3.4.3: Infectious diseases
  • 3.4.4: Cancer
  • 3.4.5: Protein quantitation
  • 3.4.6: Others
• 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 3.5.1: Hospitals and Diagnostic Centers
  • 3.5.2: Pharmaceutical and Biotech Companies
  • 3.5.3: Academic Research Centers
  • 3.5.4: Clinical Laboratories
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.2.1: North American Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.2.2: North American Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.3.1: European Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.3.2: European Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.4.1: APAC Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.4.2: APAC Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.5.1: ROW Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.5.2: ROW Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ortho Clinical Diagnostics
• 7.2: Thermos Fisher Scientific
• 7.3: BioMerieux
• 7.4: Sysmex Corporation
• 7.5: F. Hoffmann-La Roche
• 7.6: Danaher Corporation
• 7.7: Quidel Corporation
• 7.8: Bio-Rad Laboratories
• 7.9: Siemens Healthineers
• 7.10: Abbott Laboratories